Valuation: Zai Lab Limited

Market Cap 2.73B 2.43B 2.27B 2.06B 3.89B 263B 3.93B 27.41B 10.62B 134B 10.26B 10.03B 431B P/E 2026 *
-11x
P/E 2027 * -11x
Enterprise Value 2.27B 2.02B 1.89B 1.72B 3.24B 219B 3.27B 22.82B 8.84B 112B 8.54B 8.35B 359B EV / Sales 2026 *
5.21x
EV / Sales 2027 * 4.26x
Free-Float
94.05%
Yield 2026 *
-
Yield 2027 * -
1 day-4.59%
1 week-2.60%
Current month-7.63%
1 month-8.12%
3 months+27.25%
6 months+19.21%
Current year+37.93%
1 week 23.71
Extreme 23.71
26.68
1 month 23.64
Extreme 23.64
27.14
Current year 15.96
Extreme 15.96
27.5
1 year 15.96
Extreme 15.96
34.06
3 years 13.48
Extreme 13.48
44.34
5 years 13.48
Extreme 13.48
107.98
10 years 13.48
Extreme 13.48
193.54
Manager TitleAgeSince
Chief Executive Officer 61 01/04/2014
Director of Finance/CFO 58 07/07/2023
President 62 01/12/2022
Director TitleAgeSince
Chairman 61 01/04/2014
Director/Board Member 83 01/01/2017
Director/Board Member 75 01/01/2017
Date Insider Type Main position Quantity % Market Cap. Importance
19/8/26 Sell

Chief Financial Officer

-260 0.0000%
14/8/26 Exercice

Chief Financial Officer

2,927 0.0003%
12/8/26 Other

Director

-85,060 0.0075%
Change 5-day change 1-year change 3-year change Capi.($)
-4.59%-2.60%-28.12%+2.10% 2.73B
-0.61%-3.43%+39.40%+112.31% 1,019B
-1.02%-5.60%+37.67%+65.02% 617B
+1.11%-0.58%+11.10%+77.28% 464B
+0.34%-3.01%+61.21%+40.71% 356B
-0.95%-4.05%+21.60%+39.37% 333B
-1.46%-2.89%+11.84%+24.60% 267B
-1.35%-5.43%-4.69%+8.40% 244B
-1.04%-2.79%+35.52%+51.34% 218B
-1.87%-4.10%+30.92%+95.33% 179B
Average -0.67%-3.31%+21.64%+51.65% 369.99B
Weighted average by Cap. +0.42%-3.32%+30.47%+68.91%

Financials

2026 *2027 *
Net sales 436M 388M 362M 330M 622M 41.96B 628M 4.38B 1.7B 21.45B 1.64B 1.6B 68.84B 552M 491M 458M 417M 787M 53.08B 794M 5.54B 2.15B 27.13B 2.07B 2.03B 87.08B
Net income -241M -214M -200M -182M -343M -23.14B -346M -2.42B -936M -11.83B -904M -884M -37.96B -211M -188M -175M -160M -301M -20.29B -304M -2.12B -821M -10.37B -792M -775M -33.29B
Net Debt -458M -407M -380M -346M -652M -44B -658M -4.59B -1.78B -22.49B -1.72B -1.68B -72.18B -381M -338M -316M -288M -543M -36.61B -548M -3.82B -1.48B -18.72B -1.43B -1.4B -60.06B
Logo Zai Lab Limited
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Employees
1,784
Date Price Change Volume
02/10/26 USD 24.33 -4.59% 951,847
01/10/26 USD 25.50 -3.19% 545,229
30/09/26 USD 26.34 +1.58% 830,830
29/09/26 USD 25.93 +0.93% 549,095
28/09/26 USD 25.69 +2.84% 884,778
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
24.33USD
Average target price
33.14USD
Spread / Average Target
+36.21%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ZLAB Stock